/PRNewswire/ Researchers at Children s Hospital of Philadelphia (CHOP) and the University of California, Los Angeles (UCLA) have developed a computational.
Researchers at Children's Hospital of Philadelphia (CHOP) and the University of California, Los Angeles (UCLA) have developed a computational platform capable of discovering tumor antigens derived from alternative RNA splicing, expanding the pool of cancer immunotherapy targets.
Computational Tool IDs New Cancer Immunotherapy Targets miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Allogene Therapeutics, Inc. (NASDAQ:ALLO – Get Rating) – Equities researchers at Oppenheimer increased their FY2022 earnings per share estimates for shares of Allogene Therapeutics in a report released on Tuesday, August 9th. Oppenheimer analyst M. Breidenbach now expects that the company will earn ($2.43) per share for the year, up from their previous forecast of […]